Prior to launching Naya Jeevan, Dr. Hasan served in the capacity of Senior Director and Head of the US Medical Affairs Obesity team for Amylin Pharmaceuticals, Inc. Prior to relocating to California, Dr. Hasan served as the US Medical Director for Rimonabant (Acomplia) for sanofi-aventis, based out of their US headquarters in Bridgewater, NJ. During his tenure in New York City, Dr. Hasan also completed a Masters in Business Administration (MBA) from New York University’s Stern School of Business.

After migrating to the US, Dr, Hasan attended Oberlin College where he obtained a bachelor’s degree in neuroscience and biology with an additional concentration in international relations. Subsequently, Dr. Hasan moved to Harvard Medical School where he worked as a preclinical researcher along with a group of vascular surgeons at Brigham & Women’s Hospital. His research endeavors were focused on evaluating the incidence of restenosis in a rat carotid artery model following balloon angioplasty. Dr. Hasan pursued further pre-clinical and basic science research opportunities at Massachusetts General Hospital in collaboration with a group of neuro-anesthesiologists. His research there focused on the role of the NMDAR1 receptor in clinical analgesia.